For patients with mainly mild posterior circulation ischemic stroke who do not receive thrombectomy, alteplase administered ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Tenecteplase provides comparable safety and effectiveness outcomes for acute ischemic stroke as alteplase, new research ...

For patients with ischemic stroke, tenecteplase seems to be a reasonable alternative to alteplase in terms of effectiveness and safety outcomes.

A new clot-busting drug for stroke works as well as a decades-old drug Patients given tenecteplase had similar outcomes to those given alteplase Tenecteplase is easier to administer, giving doctors ...

Our study shows that tenecteplase is a safe and effective alternative to traditional treatment with alteplase, and in some cases, it could get patients on the road to recovery faster." Each year ...

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

The fibrinolytic activity of alteplase remained at >90% (compared with the standard solution) for the initial 48 hours at 2 °C, regardless of whether the solution had first been frozen (Table 1).

Acute ischemic stroke, which occurs due to a blockage in cerebral blood flow, requires prompt intervention with thrombolytic ...

The clot-buster tenecteplase is associated with a slightly higher likelihood of excellent recovery and reduced disability ...

And now, research shows that tenecteplase works just as well as the standard clot-busting drug alteplase used to treat strokes, according to findings published recently in JAMA Network Open.

The researchers observed no significant differences between tenecteplase and alteplase in terms of effectiveness or safety outcomes for the overall cohort after adjustment for covariates.